Tyrosine Kinase Inhibitor Discontinuation Safe in Pediatric Chronic Myeloid Leukemia
TKI therapy can be safely discontinued in pediatric patients with chronic-phase CML in sustained deep molecular response.
Source: cancertherapyadvisor.com
Lymphoma Study Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Lymphoma Study Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Lymphoma Study Group Today - Breaking & Trending Today
Tyrosine Kinase Inhibitor Discontinuation Safe in Pediatric Chronic Myeloid Leukemia
Study findings suggest TKI therapy can be safely discontinued in pediatric patients with chronic-phase CML in sustained deep molecular response.
Source: oncologynurseadvisor.com